AI assistant
Sending…
My Size, Inc. — Director's Dealing 2019
Jun 4, 2019
35445_dirs_2019-06-03_0fa23646-7f7f-4e93-92ca-45f242ec8e94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: My Size, Inc. (MYSZ)
CIK: 0001211805
Period of Report: 2019-05-30
Reporting Person: Luzon Ronen (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-30 | Option to purchase Common Stock (right to buy) | $0.76 | A | 100000 | Acquired | 2024-05-30 | Common Stock, $.001 par value per share (100000) | Direct |
| 2019-05-30 | Option to purchase Common Stock (right to buy) | $0.76 | A | 500000 | Acquired | 2024-05-30 | Common Stock, $.001 par value per share (500000) | Direct |
| 2019-05-30 | Option to purchase Common Stock (right to buy) | $0.76 | A | 80000 | Acquired | 2024-05-30 | Common Stock, $.001 par value per share (80000) | Indirect |
| 2019-05-30 | Option to purchase Common Stock (right to buy) | $0.76 | A | 255000 | Acquired | 2024-05-30 | Common Stock, $.001 par value per share (255000) | Indirect |
Footnotes
F1: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant.
F2: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. The option vested and became exercisable as to one-third of the total shares on January 24, 2019 and vests and becomes exercisable as to one third of the total shares on January 24, 2020 and as to the remaining shares on January 24, 2021.
F3: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).
More from My Size, Inc.
Regulatory Filings
2026
May 15
Annual Report
2026
Apr 15
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Mar 2
Director's Dealing
2025
Dec 30
Regulatory Filings
2025
Dec 29
Regulatory Filings
2025
Dec 19
Director's Dealing
2025
Dec 17
Director's Dealing
2025
Dec 17
Director's Dealing
2025
Dec 17